|
🐜
|
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
35 auth.
M. Hummel,
S. Bentink,
Hilmar Berger,
W. Klapper,
S. Wessendorf,
T. Barth,
H. Bernd,
S. Cogliatti,
J. Dierlamm,
A. Feller,
M. Hansmann,
E. Haralambieva,
L. Harder,
D. Hasenclever,
M. Kühn,
...
D. Lenze,
P. Lichter,
J. Martín-Subero,
P. Möller,
H. Müller-hermelink,
G. Ott,
R. Parwaresch,
C. Pott,
A. Rosenwald,
M. Rosolowski,
C. Schwaenen,
Benjamin Stürzenhofecker,
M. Szczepanowski,
H. Trautmann,
H. Wacker,
R. Spang,
M. Loeffler,
L. Trümper,
H. Stein,
R. Siebert
|
10 |
2006 |
10
🐜
|
|
🐜
|
T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance
17 auth.
U. Kintscher,
M. Hartge,
K. Hess,
A. Foryst-Ludwig,
M. Clemenz,
M. Wabitsch,
P. Fischer-Posovszky,
T. Barth,
D. Dragun,
T. Skurk,
...
H. Hauner,
M. Blüher,
T. Unger,
A. Wolf,
U. Knippschild,
V. Hombach,
N. Marx
|
9 |
2008 |
9
🐜
|
|
🐜
|
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
20 auth.
H. Horn,
M. Ziepert,
C. Becher,
T. Barth,
H. Bernd,
A. Feller,
W. Klapper,
M. Hummel,
H. Stein,
M. Hansmann,
...
C. Schmelter,
P. Möller,
S. Cogliatti,
M. Pfreundschuh,
N. Schmitz,
L. Trümper,
R. Siebert,
M. Loeffler,
A. Rosenwald,
G. Ott
|
9 |
2013 |
9
🐜
|
|
🐜
|
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
35 auth.
Janis A. Müller,
R. Gross,
Carina Conzelmann,
J. Krüger,
U. Merle,
Johannes Steinhart,
Tatjana Weil,
L. Koepke,
C. P. Bozzo,
C. Read,
G. Fois,
T. Eiseler,
J. Gehrmann,
Joanne van Vuuren,
Isabel M. Wessbecher,
...
M. Frick,
I. Costa,
M. Breunig,
B. Grüner,
L. Peters,
M. Schuster,
S. Liebau,
T. Seufferlein,
S. Stenger,
A. Stenzinger,
P. MacDonald,
F. Kirchhoff,
K. Sparrer,
P. Walther,
H. Lickert,
T. Barth,
M. Wagner,
J. Münch,
S. Heller,
A. Kleger
|
8 |
2021 |
8
🐜
|
|
🐜
|
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
10 auth.
Sandrine Sander,
L. Bullinger,
Kay Klapproth,
K. Fiedler,
H. Kestler,
T. Barth,
...
P. Möller,
S. Stilgenbauer,
J. Pollack,
T. Wirth
|
8 |
2008 |
8
🐜
|
|
🐜
|
Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
17 auth.
S. Lindner,
Karen Dahlke,
K. Sontheimer,
M. Hagn,
C. Kaltenmeier,
T. Barth,
Thamara Beyer,
F. Reister,
D. Fabricius,
R. Lotfi,
...
O. Lunov,
G. Nienhaus,
T. Simmet,
R. Kreienberg,
P. Möller,
H. Schrezenmeier,
B. Jahrsdörfer
|
8 |
2013 |
8
🐜
|
|
🐜
|
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
28 auth.
E. Hoster,
A. Rosenwald,
F. Berger,
H. Bernd,
S. Hartmann,
C. Loddenkemper,
T. Barth,
N. Brousse,
S. Pileri,
G. Rymkiewicz,
R. Kodet,
S. Stilgenbauer,
R. Forstpointner,
C. Thieblemont,
M. Hallek,
...
B. Coiffier,
U. Vehling‐Kaiser,
R. Bouabdallah,
L. Kanz,
M. Pfreundschuh,
C. Schmidt,
V. Ribrag,
W. Hiddemann,
M. Unterhalt,
J. Kluin-Nelemans,
O. Hermine,
M. Dreyling,
W. Klapper
|
8 |
2016 |
8
🐜
|
|
🐢
|
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.
11 auth.
S. Joos,
Christiane K. Menz,
G. Wrobel,
R. Siebert,
S. Gesk,
S. Ohl,
...
G. Mechtersheimer,
L. Trümper,
P. Möller,
P. Lichter,
T. Barth
|
8 |
2002 |
8
🐢
|
|
🐜
|
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
11 auth.
O. Determann,
E. Hoster,
G. Ott,
Heinz Wolfram Bernd,
C. Loddenkemper,
Martin Leo Hansmann,
...
T. Barth,
M. Unterhalt,
W. Hiddemann,
M. Dreyling,
W. Klapper
|
7 |
2008 |
7
🐜
|
|
🐜
|
Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2
12 auth.
U. Pannicke,
M. Hönig,
Isabell Hess,
C. Friesen,
K. Holzmann,
E. Rump,
...
T. Barth,
M. Rojewski,
A. Schulz,
T. Boehm,
W. Friedrich,
K. Schwarz
|
7 |
2009 |
7
🐜
|
|
🐜
|
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.
22 auth.
G. Ott,
M. Ziepert,
W. Klapper,
H. Horn,
M. Szczepanowski,
H. Bernd,
C. Thorns,
A. Feller,
D. Lenze,
M. Hummel,
...
H. Stein,
H. Müller-hermelink,
Matthias Frank,
M. Hansmann,
T. Barth,
P. Möller,
S. Cogliatti,
M. Pfreundschuh,
N. Schmitz,
L. Trümper,
M. Loeffler,
A. Rosenwald
|
7 |
2010 |
7
🐜
|
|
🐜
|
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
23 auth.
A. Staiger,
M. Ziepert,
H. Horn,
D. Scott,
T. Barth,
H. Bernd,
A. Feller,
W. Klapper,
M. Szczepanowski,
M. Hummel,
...
H. Stein,
D. Lenze,
M. Hansmann,
S. Hartmann,
P. Möller,
S. Cogliatti,
G. Lenz,
L. Trümper,
M. Löffler,
N. Schmitz,
M. Pfreundschuh,
A. Rosenwald,
G. Ott
|
7 |
2017 |
7
🐜
|
